Hans Nordgren

7.4k total citations · 3 hit papers
63 papers, 5.1k citations indexed

About

Hans Nordgren is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Hans Nordgren has authored 63 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 22 papers in Cancer Research and 15 papers in Molecular Biology. Recurrent topics in Hans Nordgren's work include Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (11 papers) and Cancer Genomics and Diagnostics (6 papers). Hans Nordgren is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (11 papers) and Cancer Genomics and Diagnostics (6 papers). Hans Nordgren collaborates with scholars based in Sweden, United States and Denmark. Hans Nordgren's co-authors include Jonas Bergh, Lars Holmberg, Johanna Smeds, A. Lindgren, Stephen B. Fox, Adrian L. Harris, Christos Sotiriou, Benjamin Haibe‐Kains, Sherene Loi and Pratyaksha Wirapati and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Hans Nordgren

62 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

2006 1.5k citations Johanna Smeds, Hans Nordgren et al. JNCI Journal of the National Cancer Institute profile →
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

2005 613 citations Yudi Pawitan, Judith Bjöhle et al. Breast Cancer Research profile →
Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer

2006 543 citations Anna V. Ivshina, Joshy George et al. Cancer Research profile →

Peers

Countries citing papers authored by Hans Nordgren

Since Specialization

Citations

This map shows the geographic impact of Hans Nordgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Nordgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Nordgren more than expected).

Fields of papers citing papers by Hans Nordgren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Nordgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Nordgren. The network helps show where Hans Nordgren may publish in the future.

Co-authorship network of co-authors of Hans Nordgren

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Nordgren. A scholar is included among the top collaborators of Hans Nordgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Nordgren. Hans Nordgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cervical metastasis from Spitz nevus of the buccal mucosa 2008 ·Melanoma Research ·Ulf K. Zätterström, Andreas Thor, Hans Nordgren	6
2	EGFR, HER2, and HER3 Expression in Laryngeal Primary Tumors and Corresponding Metastases 2008 ·Annals of Surgical Oncology ·Qichun Wei, Liming Sheng, Yongjie Shui, (unknown), Hans Nordgren, Jörgen Carlsson	53
3	Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome 2007 ·Annals of Oncology ·Jenny Bergqvist, John Öhd, Johanna Smeds, Sigrid Klaar, Jorma Isola, Hans Nordgren, Göran Elmberger, Henrik Hellborg, Judith Bjöhle, Alexander Borg, Lambert Skoog, Jonas Bergh	31
4	A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer 2007 ·European Journal of Cancer ·Kenneth Villman, John Öhd, Elisabet Lidbrink, Lena Malmberg, Birgitta Lindh, Carl Blomqvist, Hans Nordgren, Jonas Bergh, (unknown), Johan Ahlgren	18
5	Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer breakdown → 2006 ·Cancer Research ·Anna V. Ivshina, Joshy George, O. V. Sen’ko, Benjamin Mow, Thomas Choudary Putti, Johanna Smeds, Thomas Lindahl, Yudi Pawitan, Per Hall, Hans Nordgren, John E.L. Wong, Edison T. Liu, Jonas Bergh, Vladimir A. Kuznetsov, Lance D. Miller	543
6	Activated ERK1/2 and phosphorylated oestrogen receptor α are associated with improved breast cancer survival in women treated with tamoxifen 2006 ·European Journal of Cancer ·Jenny Bergqvist, Göran Elmberger, John Öhd, Barbro Linderholm, Judith Bjöhle, Henrik Hellborg, Hans Nordgren, (unknown), Lambert Skoog, Jonas Bergh	43
7	Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast – Results from the Swedish randomised trial 2006 ·European Journal of Cancer ·Anita Ringberg, Hans Nordgren, (unknown), Ingrid Idvall, Hans Garmo, Bengt Granstrand, L-G Arnesson, Kerstin Sandelin, Arne Wallgren, H. Anderson, Stefan O. Emdin, Lars Holmberg	58
8	Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts breakdown → 2005 ·Breast Cancer Research ·Yudi Pawitan, Judith Bjöhle, Lukas C. Amler, (unknown), Suzanne Egyházi, Per Hall, Xia Han, Lars Holmberg, Fei Huang, Sigrid Klaar, Edison T. Liu, Lance D. Miller, Hans Nordgren, Alexander Ploner, Kerstin Sandelin, Peter Shaw, Johanna Smeds, Lambert Skoog, Sara Wedrén, Jonas Bergh	613
9	HER-2, EGFR, COX-2 Expression status correlated to microvessel density and survival in resected non-small cell lung cancer 2004 ·Acta Oncologica ·Daniel Brattström, Kenneth Wester, Michael Bergqvist, Patrik Hesselius, Per‐Uno Malmström, Hans Nordgren, Gunnar Wagenius, Ola Brodin	32
10	Ductal Carcinoma in Situ of the Breast: a New Phenotype Classification System and its Relation to Prognosis 2002 ·Breast Cancer Research and Treatment ·Fredrik Wärnberg, Patrizia Casalini, Hans Nordgren, Leif Bergkvist, Lars Holmberg, (unknown)	16
11	Tumour markers in breast carcinoma correlate with grade rather than with invasiveness 2001 ·British Journal of Cancer ·Fredrik Wärnberg, Hans Nordgren, Leif Bergkvist, Lars Holmberg	102
12	E4, A New Monoclonal Antibody Identifying a Human Prostatic Cell Surface Antigen 1997 ·Cancer Biotherapy and Radiopharmaceuticals ·Sten Nilsson, Magnus Essand, (unknown), (unknown), Hans Nordgren, (unknown)	2
13	Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy 1997 ·Annals of Oncology ·Göran Liljegren, A. Lindgren, Jonas Bergh, Hans Nordgren, Làszló Tabár, Lars Holmberg	39
14	Response on p53 1996 ·JNCI Journal of the National Cancer Institute ·S. Sjögren, Mats Inganäs, Leona Holmberg, Torbjörn Norberg, Hans Nordgren, A. Lindgren, Jonas Bergh	4
15	Estramustine-Binding Protein (EMBP) in Renal Cell Carcinoma Immunohistochemistry, Immunoscintigraphy and in Vitro Estramustine Effects 1996 ·Acta Oncologica ·M Edgren, Jan‐Erik Westlin, Henry Letocha, Hans Nordgren, Karl‐Mikael Kälkner, Sten Nilsson	3
16	Bcl-2 immunoreactivity in prostate tumorigenesis in relation to prostatic intraepithelial neoplasia, grade, hormonal status, metastatic growth and survival 1996 ·Urological Research ·Pär Stattin, Jan‐Erik Damber, Lars Karlberg, Hans Nordgren, Anders Bergh	38
17	The subacromial bursa and the impingement syndrome: A clinical and histological study of 30 cases 1993 ·Acta Orthopaedica Scandinavica ·Hans Rahme, Hans Nordgren, Hans Hamberg, Carl-Einar Westerberg	22
18	Modal DNA Values and Estramustine-Binding Protein (EMBP) as Prognostic Markers in Prostatic Cancer 1991 ·Acta Oncologica ·Hans Nordgren, Sten Nilsson, (unknown), Pär Stattin, (unknown), T Heiden, Leif Bergkvist, Lars Karlberg, Cecilia Lundholm, (unknown), Peter Strang, R. Bergström, Bernhard Tribukait	8
19	Histopathological and immunohistochemical analysis of lung tumors: Description of a convenient technique for use with fine needle biopsy 1989 ·Apmis ·Hans Nordgren, Sten Nilsson, (unknown), Jan Pontén, Jonas Bergh	2
20	Rett syndrome: Spinal cord neuropathology 1988 ·Pediatric Neurology ·Anders Oldfors, Bengt Hagberg, Hans Nordgren, Patrick Sourander, Ingegerd Witt‐Engerström	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact